• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国确立头孢喹肟对副猪嗜血杆菌临床断点的证据

Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China.

作者信息

Mi Kun, Sun Da, Li Mei, Hao Haihong, Zhou Kaixiang, Liu Zhenli, Yuan Zonghui, Huang Lingli

机构信息

National Reference Laboratory of Veterinary Drug Residues (HZAU), Wuhan 430000, China.

MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University, Wuhan 430000, China.

出版信息

Pathogens. 2021 Jan 22;10(2):105. doi: 10.3390/pathogens10020105.

DOI:10.3390/pathogens10020105
PMID:33498972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7912692/
Abstract

can cause high morbidity and mortality in swine. Cefquinome possesses excellent antibacterial activity against pathogens causing diseases of the respiratory tract. This study aimed to establish the clinical breakpoint (CBP) of cefquinome against and to monitor the resistance change. Referring to the minimum inhibitory concentration (MIC) distribution of cefquinome against 131 isolates, the MIC and MIC were determined to be 0.125 and 1 μg/mL, respectively. And the epidemiological cutoff (ECOFF) value was 1 μg/mL. was selected as a representative strain for the pharmacodynamic (PD) experiment, pharmacokinetic (PK) experiment and clinical experiments. The PK/PD index values, area under concentration-time curve (AUC)/MIC, of the bacteriostatic, bactericidal, and bacterial elimination effects were 23, 41, and 51 h, respectively. The PK/PD cutoff was calculated as 0.125 μg/mL by Monte Carlo simulation (MCS), and the clinical cutoff was 0.25-4 μg/mL by WindoW. Combing these three values, the CBP of cefquinome against was found to be 1 μg/mL. In conclusion, this was the first study to integrate various cutoffs to establish the CBP in the laboratory. It is helpful to distinguish wild type and reduce the probability of treatment failure.

摘要

可导致猪的高发病率和死亡率。头孢喹肟对引起呼吸道疾病的病原体具有优异的抗菌活性。本研究旨在确定头孢喹肟对[病原体名称未给出]的临床断点(CBP)并监测耐药性变化。参考头孢喹肟对131株[菌株名称未给出]的最低抑菌浓度(MIC)分布,确定MIC50和MIC90分别为0.125和1μg/mL。且流行病学临界值(ECOFF)为1μg/mL。[菌株名称未给出]被选为药效学(PD)实验、药代动力学(PK)实验和临床试验的代表性菌株。抑菌、杀菌和细菌清除作用的药代动力学/药效学(PK/PD)指数值,即浓度-时间曲线下面积(AUC)/MIC,分别为23、41和51小时。通过蒙特卡洛模拟(MCS)计算得出PK/PD临界值为0.125μg/mL,通过WindoW得出临床临界值为0.25 - 4μg/mL。综合这三个值,发现头孢喹肟对[菌株名称未给出]的CBP为1μg/mL。总之,这是首次在实验室中整合各种临界值来确定CBP的研究。有助于区分野生型[菌株名称未给出]并降低治疗失败的概率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5e/7912692/26bffa8c1583/pathogens-10-00105-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5e/7912692/4e1612b4c388/pathogens-10-00105-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5e/7912692/60bb737257f1/pathogens-10-00105-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5e/7912692/20aa4135aec9/pathogens-10-00105-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5e/7912692/26bffa8c1583/pathogens-10-00105-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5e/7912692/4e1612b4c388/pathogens-10-00105-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5e/7912692/60bb737257f1/pathogens-10-00105-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5e/7912692/20aa4135aec9/pathogens-10-00105-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c5e/7912692/26bffa8c1583/pathogens-10-00105-g004.jpg

相似文献

1
Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China.中国确立头孢喹肟对副猪嗜血杆菌临床断点的证据
Pathogens. 2021 Jan 22;10(2):105. doi: 10.3390/pathogens10020105.
2
In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis.头孢喹肟对副猪嗜血杆菌的体外动态药代动力学/药效学(PK/PD)建模及PK/PD界值
BMC Vet Res. 2015 Feb 13;11:33. doi: 10.1186/s12917-015-0343-7.
3
Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.猪胸膜肺炎放线杆菌的流行病学和 PK/PD 截断值的确定及基于 PK/PD 的替米考星剂量评估。
BMC Vet Res. 2020 Mar 5;16(1):81. doi: 10.1186/s12917-020-02300-y.
4
Exploration of Clinical Breakpoint of Danofloxacin for in Plasma and in PELF.达氟沙星在血浆和嗜肺军团菌中的临床断点探索。
Antibiotics (Basel). 2021 Jul 2;10(7):808. doi: 10.3390/antibiotics10070808.
5
Determination of Susceptibility Breakpoint for Cefquinome against in Pigs.头孢喹肟对猪源[具体细菌名称未给出]的药敏断点测定
Antibiotics (Basel). 2021 Aug 9;10(8):958. doi: 10.3390/antibiotics10080958.
6
In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.马波沙星对副猪嗜血杆菌的体外动态药代动力学/药效学(PK/PD)研究及慢性阻塞性肺疾病(COPD)研究
BMC Vet Res. 2015 Dec 1;11:293. doi: 10.1186/s12917-015-0604-5.
7
The Epidemiologic and Pharmacodynamic Cutoff Values of Tilmicosin against Haemophilus parasuis.替米考星对副猪嗜血杆菌的流行病学及药效学临界值
Front Microbiol. 2016 Mar 22;7:385. doi: 10.3389/fmicb.2016.00385. eCollection 2016.
8
Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against and in Piglets.达氟沙星对仔猪体内[具体细菌名称1]和[具体细菌名称2]的药代动力学/药效学靶点及临界值比较
Front Vet Sci. 2022 Feb 2;9:811967. doi: 10.3389/fvets.2022.811967. eCollection 2022.
9
Optimal Regimens and Cutoff Evaluation of Tildipirosin Against .替地米星针对……的最佳用药方案及临界值评估
Front Pharmacol. 2018 Jul 26;9:765. doi: 10.3389/fphar.2018.00765. eCollection 2018.
10
Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.整合药代动力学与药效动力学以优化多西环素对猪副猪嗜血杆菌的给药剂量
J Vet Pharmacol Ther. 2018 Oct;41(5):706-718. doi: 10.1111/jvp.12512. Epub 2018 Apr 25.

引用本文的文献

1
A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs.建立生理药代动力学模型优化头孢喹肟在猪体内的给药方案和停药期。
PLoS Comput Biol. 2023 Aug 16;19(8):e1011331. doi: 10.1371/journal.pcbi.1011331. eCollection 2023 Aug.
2
Kill Rate and Evaluation of PK/PD Integration of Cefquinome Against .头孢喹肟的杀菌率及药代动力学/药效学整合评价 针对……
Front Vet Sci. 2021 Dec 13;8:751957. doi: 10.3389/fvets.2021.751957. eCollection 2021.
3
Prudent Use of Tylosin for Treatment of Based on Its Clinical Breakpoint and Lung Microbiota Shift.

本文引用的文献

1
Global trends in antimicrobial resistance in animals in low- and middle-income countries.中低收入国家动物中的抗微生物药物耐药性全球趋势。
Science. 2019 Sep 20;365(6459). doi: 10.1126/science.aaw1944.
2
VetCAST Method for Determination of the Pharmacokinetic-Pharmacodynamic Cut-Off Values of a Long-Acting Formulation of Florfenicol to Support Clinical Breakpoints for Florfenicol Antimicrobial Susceptibility Testing in Cattle.用于确定氟苯尼考长效制剂药代动力学-药效学临界值以支持牛氟苯尼考抗菌药敏试验临床断点的VetCAST方法
Front Microbiol. 2019 Jun 12;10:1310. doi: 10.3389/fmicb.2019.01310. eCollection 2019.
3
基于泰乐菌素的临床断点和肺部微生物群变化谨慎使用其进行治疗
Front Microbiol. 2021 Sep 9;12:712473. doi: 10.3389/fmicb.2021.712473. eCollection 2021.
4
Determination of Susceptibility Breakpoint for Cefquinome against in Pigs.头孢喹肟对猪源[具体细菌名称未给出]的药敏断点测定
Antibiotics (Basel). 2021 Aug 9;10(8):958. doi: 10.3390/antibiotics10080958.
Semi-Mechanistic Modeling of Florfenicol Time-Kill Curves and Dose Fractionation for Calf Respiratory Pathogens.
氟苯尼考对犊牛呼吸道病原体的时间-杀菌曲线及剂量分割的半机制模型
Front Microbiol. 2019 Jun 11;10:1237. doi: 10.3389/fmicb.2019.01237. eCollection 2019.
4
Optimal Regimens and Cutoff Evaluation of Tildipirosin Against .替地米星针对……的最佳用药方案及临界值评估
Front Pharmacol. 2018 Jul 26;9:765. doi: 10.3389/fphar.2018.00765. eCollection 2018.
5
Epidemiology of isolates from pigs in China using serotyping, antimicrobial susceptibility, biofilm formation and ERIC-PCR genotyping.利用血清分型、抗菌药敏试验、生物膜形成及ERIC-PCR基因分型对中国猪源分离株进行的流行病学研究
PeerJ. 2018 Jun 13;6:e5040. doi: 10.7717/peerj.5040. eCollection 2018.
6
Differential drug susceptibility patterns of Mycobacterium chimaera and other members of the Mycobacterium avium-intracellulare complex.奇曼分枝杆菌和鸟分枝杆菌-胞内分枝杆菌复合群其他成员的药物敏感性差异模式。
Clin Microbiol Infect. 2019 Mar;25(3):379.e1-379.e7. doi: 10.1016/j.cmi.2018.06.010. Epub 2018 Jun 12.
7
Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.头孢喹肟在猪组织笼感染模型中对胸膜肺炎放线杆菌的药代动力学/药效学评估。
Vet Microbiol. 2018 Jun;219:100-106. doi: 10.1016/j.vetmic.2018.02.027. Epub 2018 Mar 6.
8
Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.整合药代动力学与药效动力学以优化多西环素对猪副猪嗜血杆菌的给药剂量
J Vet Pharmacol Ther. 2018 Oct;41(5):706-718. doi: 10.1111/jvp.12512. Epub 2018 Apr 25.
9
Characterization of antimicrobial resistance genes in isolated from pigs in China.对从中国猪身上分离出的抗菌药物耐药基因的表征。
PeerJ. 2018 Apr 9;6:e4613. doi: 10.7717/peerj.4613. eCollection 2018.
10
Antimicrobial susceptibility of Haemophilus parasuis isolates from Germany by use of a proposed standard method for harmonized testing.德国副猪嗜血杆菌分离株的抗菌敏感性,采用了一种经过提议的标准化方法进行协调测试。
Vet Microbiol. 2018 Apr;217:32-35. doi: 10.1016/j.vetmic.2018.02.017. Epub 2018 Feb 17.